SEC Form 4 Summary RPRX

Royalty Pharma Executive Marshall Urist Reports $1.74 Million in Share Sales

Royalty Pharma executive Marshall Urist sold 25,000 RPRX shares for $1,737,490.29 in two transactions on November 16, 2026.

Transaction Value:
$1,737,490.29
Shares transacted:
25,000
Average price:
$69.50
Insider:

The Form 4 filing, a report of an insider's stock trades, was filed on November 18, 2026. The sales took place two days earlier. It lists Marshall Urist as Royalty Pharma plc's executive vice president for research and investments.

Transaction details

Transaction
Date of Earliest Transaction2026-11-16
Date of Latest Transaction2026-11-16
Buy/Sellsell
Transaction Count2
Shares Transacted25,000
Price$69.50
Total Transaction Value$1,737,490.29
Insider
Ticker SymbolRPRX
CompanyRoyalty Pharma plc
Insider NameUrist Marshall
Insider TitleEVP, Research & Investments
Sector - IndustryHealthcare - Biotechnology
Holdings
Total Shares Owned After Transaction125,000
Position Size Change16.67%
Filing
Filing Date2026-11-18
SEC LinkView filing

FAQ

What type of transaction is this?

These were share sales, reported with transaction code S. The filing covers two sale transactions by Marshall Urist.

What was the average price of the transaction?

The average price was $69.50 per share, rounded from $69.49961168. That average covers the 25,000 shares sold across both transactions. Separate prices for each sale are not available in the provided details.

How did this transaction affect the insider's holdings?

Marshall Urist sold 25,000 shares and reported owning 125,000 shares afterward. The shares sold were 16.67% of his reported shares before the sales. Those figures show a reported balance of 150,000 shares before the sales.

What's the total transaction value?

The two sales had a total value of $1,737,490.29, rounded to the nearest cent. That amount covers both transactions together.

Are there any special circumstances around this transaction?

The filing information includes a Rule 10b5-1 trading-plan reference. These plans set trading instructions ahead of time. The available details do not show whether that reference covers both sales or only part of the filing. Footnote text and plan terms are not available, so the plan's start date and trading schedule remain unknown.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.